Insulin Sensitivity After Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Insulin Sensitivity After Breast Cancer — Stella

Recruiting

Back to Insulin Sensitivity/Resistance trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Denmark

University of Copenhagen, Copenhagen, DK

Key details

Sponsor

University of Copenhagen

Enrollment target

~24 participants

Started

August 2021

Primary completion

December 2022

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 45 Years

Sex

Female only

Last updated August 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov